Total Payments
$157,577
2024 Payments
$12,323
Companies
37
Transactions
321
Medicare Patients
6,981
Medicare Billing
$2.8M
Payment Breakdown by Category
Other$108,355 (68.8%)
Consulting$22,827 (14.5%)
Travel$14,160 (9.0%)
Food & Beverage$12,069 (7.7%)
Education$166.38 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105,318 | 28 | 66.8% |
| Consulting Fee | $22,827 | 12 | 14.5% |
| Travel and Lodging | $14,160 | 47 | 9.0% |
| Food and Beverage | $12,069 | 219 | 7.7% |
| Honoraria | $2,590 | 2 | 1.6% |
| Entertainment | $447.19 | 9 | 0.3% |
| Education | $166.38 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $103,392 | 99 | $0 (2021) |
| Astellas Pharma US Inc | $17,769 | 18 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $8,344 | 15 | $0 (2024) |
| Allergan, Inc. | $7,655 | 23 | $0 (2021) |
| Dutch Ophthalmic, USA | $3,137 | 10 | $0 (2023) |
| Alimera Sciences, Inc. | $3,054 | 13 | $0 (2024) |
| ThromboGenics, Inc. | $2,691 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $2,220 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $1,620 | 17 | $0 (2024) |
| Cardinal Health 108 LLC | $1,575 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,323 | 43 | Regeneron Pharmaceuticals, Inc. ($8,261) |
| 2023 | $18,697 | 32 | Astellas Pharma US Inc ($17,708) |
| 2022 | $4,983 | 31 | Dutch Ophthalmic, USA ($2,495) |
| 2021 | $518.18 | 17 | Regeneron Healthcare Solutions, Inc. ($175.25) |
| 2020 | $5,098 | 19 | Allergan, Inc. ($2,492) |
| 2019 | $107,850 | 112 | Novartis Pharmaceuticals Corporation ($102,115) |
| 2018 | $6,612 | 36 | Allergan Inc. ($4,809) |
| 2017 | $1,495 | 31 | Optos, Inc. ($425.25) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,086.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,896.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,896.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,086.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $89.17 | General |
| 10/18/2024 | EyePoint Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $233.86 | General |
| 10/18/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $149.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $130.17 | General |
| 10/18/2024 | Astellas Pharma Global Development | Izervay (Drug) | Food and Beverage | In-kind items and services | $37.78 | General |
| Category: Ophthalmology | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $36.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $174.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $116.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $91.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $84.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $68.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $47.28 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $71.26 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/10/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $574.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/10/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: EYE CARE | ||||||
| 08/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,948 | 8,670 | $1.8M | $1.1M |
| 2022 | 12 | 1,804 | 4,123 | $1.2M | $698,896 |
| 2021 | 15 | 1,945 | 4,078 | $2.4M | $723,907 |
| 2020 | 16 | 1,284 | 2,091 | $1.3M | $283,609 |
Total Patients
6,981
Total Services
18,962
Medicare Billing
$2.8M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 137 | 1,036 | $1.0M | $714,058 | 68.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 15 | 3,720 | $186,000 | $108,354 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 494 | 843 | $109,590 | $73,530 | 67.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 179 | 821 | $123,150 | $66,744 | 54.2% |
| 92134 | Imaging of retina | Office | 2023 | 627 | 1,565 | $146,840 | $44,515 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 289 | 289 | $72,250 | $33,163 | 45.9% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 14 | 14 | $20,600 | $12,257 | 59.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 50 | 225 | $22,500 | $11,789 | 52.4% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 38 | 42 | $29,400 | $7,572 | 25.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 80 | 86 | $3,010 | $1,542 | 51.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 12 | 15 | $1,400 | $438.21 | 31.3% |
| 92250 | Photography of the retina | Office | 2023 | 13 | 14 | $1,400 | $341.28 | 24.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 83 | 670 | $746,000 | $479,335 | 64.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 153 | 692 | $109,050 | $57,175 | 52.4% |
| 92134 | Imaging of retina | Office | 2022 | 558 | 1,310 | $93,095 | $37,886 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 319 | 420 | $56,120 | $37,797 | 67.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 319 | 319 | $79,750 | $35,982 | 45.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 80 | 350 | $38,600 | $18,115 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 210 | $24,630 | $12,194 | 49.5% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Facility | 2022 | 12 | 16 | $28,300 | $11,850 | 41.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 30 | 33 | $23,100 | $6,061 | 26.2% |
| 92250 | Photography of the retina | Office | 2022 | 36 | 38 | $3,800 | $904.28 | 23.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 43 | 43 | $1,625 | $798.84 | 49.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 11 | 22 | $2,040 | $797.66 | 39.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 78 | 606 | $1.6M | $444,240 | 28.2% |
About Dr. Hemang Pandya, M.D
Dr. Hemang Pandya, M.D is a Ophthalmology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1700100229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hemang Pandya, M.D has received a total of $157,577 in payments from pharmaceutical and medical device companies, with $12,323 received in 2024. These payments were reported across 321 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($105,318).
As a Medicare-enrolled provider, Pandya has provided services to 6,981 Medicare beneficiaries, totaling 18,962 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Plano, TX
- Active Since 03/26/2010
- Last Updated 02/18/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1700100229
Products in Payments
- BEOVU (Drug) $44,491
- EYLEA HD (Biological) $9,523
- OZURDEX (Drug) $7,332
- EVA, combined machine (Device) $2,943
- Jetrea (Drug) $2,691
- ILUVIEN (Drug) $2,642
- Lucentis (Biological) $786.44
- ACTHAR (Biological) $586.29
- RTH258B (Drug) $504.71
- California (Device) $425.25
- EYLEA (Biological) $394.89
- YUTIQ (Drug) $368.24
- Vabysmo (Drug) $357.44
- Monaco (Device) $279.05
- EVA Ophthalmic Surgical System (Device) $194.14
- Cimerli (Biological) $191.95
- VYZULTA (Drug) $187.60
- Izervay (Drug) $171.04
- STELLARIS PC (Device) $166.93
- Humira (Biological) $132.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Plano
Dr. Dain Brooks, Md, MD
Ophthalmology — Payments: $18,457
Ophthalmology $18,457
Shashi Alloju, Md, MD
Ophthalmology — Payments: $9,917
Ophthalmology $9,917
Dr. Connor Smith, M.d, M.D
Ophthalmology — Payments: $5,615
Ophthalmology $5,615
Dr. Abdulfatah Ali, M.d, M.D
Ophthalmology — Payments: $5,205
Ophthalmology $5,205
Patricia Fortin, Md, MD
Ophthalmology — Payments: $4,253
Ophthalmology $4,253
Dr. Ellen Ngo, M.d, M.D
Ophthalmology — Payments: $3,681
Ophthalmology $3,681